[Congressional Bills 114th Congress] [From the U.S. Government Publishing Office] [H.R. 2820 Reported in House (RH)] Union Calendar No. 183 114th CONGRESS 1st Session H. R. 2820 [Report No. 114-242] To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES June 18, 2015 Mr. Smith of New Jersey (for himself, Ms. Matsui, Mr. Jolly, and Mr. Fattah) introduced the following bill; which was referred to the Committee on Energy and Commerce September 8, 2015 Additional sponsors: Mr. Grijalva, Mr. Huelskamp, Mr. Bilirakis, Mr. Murphy of Pennsylvania, Mrs. Ellmers of North Carolina, Mr. Roskam, Mr. Harris, Mr. DeFazio, Mr. Aderholt, Mr. Nolan, Mr. Newhouse, Mr. Ross, Mr. Lance, Mr. Barletta, Mr. Burgess, Ms. Eshoo, Mr. Loebsack, Mr. Hudson, and Ms. Pingree September 8, 2015 Committed to the Committee of the Whole House on the State of the Union and ordered to be printed _______________________________________________________________________ A BILL To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
HR 2820 - 114
Reported in House
Stem Cell Therapeutic and Research Reauthorization Act of 2015
3
Sections
2
Dollar amounts
0
Deadlines and effective dates
Sep 8, 2015
Text version date
Largest fiscal amounts
$23,000,000 2
Top statutory references
42 U.S.C. 274k 1
42 U.S.C. 274m 1
Official source
Official PDF
Preview the source PDF from the official text formats without leaving this page, or open the original file in a new tab.
Structured text
Sec. 1.
SECTION 1. SHORT TITLE.
SECTION 1. SHORT TITLE. This Act may be cited as the ``Stem Cell Therapeutic and Research Reauthorization Act of 2015''.
Sec. 2.
SEC. 2. AMENDMENTS TO THE STEM CELL THERAPEUTIC AND RESEARCH ACT OF
SEC. 2. AMENDMENTS TO THE STEM CELL THERAPEUTIC AND RESEARCH ACT OF 2005. (a) Cord Blood Inventory.--Section 2 of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended in subsection (h)-- (1) in paragraph (1)-- (A) by striking ``$23,000,000 for each of fiscal years 2011 through 2014 and''; and (B) by inserting before the period at the end the following: ``and $23,000,000 for each of fiscal years 2016 through 2020''; and (2) in paragraph (2), by striking ``2011 through 2015'' and inserting ``2015 through 2020''. (b) National Program.--Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended by striking ``2011 through 2014'' and inserting ``2016 through 2020''. Union Calendar No. 183 114th CONGRESS 1st Session H. R. 2820 [Report No. 114-242] _______________________________________________________________________ A BILL To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes. _______________________________________________________________________ September 8, 2015 Committed to the Committee of the Whole House on the State of the Union and ordered to be printed
Cached official text analysis. This viewer uses cached official bill text and deterministic section, phrase, fiscal, agency, deadline, and statutory-reference extraction. The analysis is navigation support, not a legal interpretation; consult the official text for authoritative wording.
Sign in to use bill text research tools
Text find, signal filters, structured drilldowns, match navigation, and bill text bookmarks are account features. Create a free account to use them and return to this bill text.